Worsening glycemic control in youth with type 2 diabetes during COVID-19.
A1C (or HbA1c)
Coronavirus – COVID-19
adolescent
glycemic control
hemoglobin A1c
type 2 diabetes (T2D)
Journal
Frontiers in clinical diabetes and healthcare
ISSN: 2673-6616
Titre abrégé: Front Clin Diabetes Healthc
Pays: Switzerland
ID NLM: 9918266295306676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
06
2022
accepted:
12
08
2022
medline:
31
3
2023
entrez:
30
3
2023
pubmed:
31
3
2023
Statut:
epublish
Résumé
The COVID-19 pandemic has disproportionately affected minority and lower socioeconomic populations, who also have higher rates of type 2 diabetes (T2D). The impact of virtual school, decreased activity level, and worsening food insecurity on pediatric T2D is unknown. The goal of this study was to evaluate weight trends and glycemic control in youth with existing T2D during the COVID-19 pandemic. A retrospective study of youth <21 years of age diagnosed with T2D prior to March 11, 2020 was conducted at an academic pediatric diabetes center to compare glycemic control, weight, and BMI in the year prior to the COVID-19 pandemic (March 2019-2020) to during COVID-19 (March 2020-2021). Paired t-tests and linear mixed effects models were used to analyze changes during this period. A total of 63 youth with T2D were included (median age 15.0 (IQR 14-16) years, 59% female, 74.6% black, 14.3% Hispanic, 77.8% with Medicaid insurance). Median duration of diabetes was 0.8 (IQR 0.2-2.0) years. There was no difference in weight or BMI from the pre-COVID-19 period compared to during COVID-19 (Weight: 101.5 v 102.9 kg, p=0.18; BMI: 36.0 v 36.1 kg/m2, p=0.72). Hemoglobin A1c significantly increased during COVID-19 (7.6% vs 8.6%, p=0.0002). While hemoglobin A1c increased significantly in youth with T2D during the COVID-19 pandemic, there was no significant change in weight or BMI possibly due to glucosuria associated with hyperglycemia. Youth with T2D are at high risk for diabetes complications, and the worsening glycemic control in this population highlights the need to prioritize close follow-up and disease management to prevent further metabolic decompensation.
Identifiants
pubmed: 36992756
doi: 10.3389/fcdhc.2022.968113
pmc: PMC10012097
doi:
Types de publication
Journal Article
Langues
eng
Pagination
968113Informations de copyright
Copyright © 2022 Bharill, Lin, Arking, Brown, West, Busin, Magge and Wolf.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Children (Basel). 2021 Feb 12;8(2):
pubmed: 33673078
JMIR Pediatr Parent. 2020 Oct 12;3(2):e23057
pubmed: 33001834
J Clin Endocrinol Metab. 2011 Jan;96(1):159-67
pubmed: 20962021
Pediatr Diabetes. 2019 Nov;20(7):871-879
pubmed: 31418516
Nutrients. 2020 Sep 30;12(10):
pubmed: 33008059
Early Child Educ J. 2021;49(5):915-923
pubmed: 33942007
JAMA. 2014 May 7;311(17):1778-86
pubmed: 24794371
JAMA. 2021 Oct 12;326(14):1434-1436
pubmed: 34448817
Diabetes Technol Ther. 2021 Sep;23(9):632-641
pubmed: 34086503
Prev Chronic Dis. 2005 Nov;2 Spec no:A04
pubmed: 16263037
Diabet Med. 2011 May;28(5):519-24
pubmed: 21214625
Front Endocrinol (Lausanne). 2021 May 27;12:650492
pubmed: 34122332
Pediatr Diabetes. 2020 Nov;21(7):1116-1125
pubmed: 33103329
Lancet Diabetes Endocrinol. 2018 Jan;6(1):69-80
pubmed: 28847479
Ann Intern Med. 2021 Mar;174(3):362-373
pubmed: 33253040
Curr Diab Rep. 2018 May 8;18(6):36
pubmed: 29737424
Pediatr Diabetes. 2020 Feb;21(1):135-142
pubmed: 31644828
Diabetes Care. 2021 Jan;44(Suppl 1):S180-S199
pubmed: 33298424
N Engl J Med. 2021 Jul 29;385(5):416-426
pubmed: 34320286
Diabetes Care. 2014;37(3):780-8
pubmed: 24194506
N Engl J Med. 2017 Apr 13;376(15):1419-1429
pubmed: 28402773
Nat Rev Endocrinol. 2020 Jun;16(6):321-331
pubmed: 32203408
Curr Diab Rep. 2015 Jan;15(1):568
pubmed: 25398207
Diabetes Care. 2018 Feb;41(2):233-240
pubmed: 29358467
Curr Diab Rep. 2014 Aug;14(8):508
pubmed: 24919749
Obesity (Silver Spring). 2020 Aug;28(8):1382-1385
pubmed: 32352652
Pediatr Diabetes. 2022 Jun;23(4):439-446
pubmed: 35138021
Int J Environ Res Public Health. 2021 Apr 18;18(8):
pubmed: 33919524
Diabetes Res Clin Pract. 2018 May;139:24-31
pubmed: 29427697
BMC Public Health. 2020 Sep 4;20(1):1351
pubmed: 32887592
Clin Obes. 2020 Dec;10(6):e12416
pubmed: 33009706
J Pediatr Nurs. 2021 Jan-Feb;56:90-98
pubmed: 33293199
Diabetes Care. 2021 Dec;44(12):2812
pubmed: 34518378
Diabetes Care. 2016 Sep;39(9):1635-42
pubmed: 27486237
J Racial Ethn Health Disparities. 2021 Oct;8(5):1300-1314
pubmed: 33057998
Pediatrics. 2020 Sep;146(3):
pubmed: 32554517
Front Endocrinol (Lausanne). 2021 Aug 10;12:703905
pubmed: 34447352
Endocrine. 2021 Sep;73(3):499-506
pubmed: 34244903
JAMA. 2016 Jun 7;315(21):2292-9
pubmed: 27272581
JAMA. 2020 Jun 23;323(24):2466-2467
pubmed: 32391864
Drugs. 2015 Apr;75(6):577-87
pubmed: 25851098
Pediatrics. 2021 May;147(5):
pubmed: 33653879